ReviewMolecular neurobiology2025
NETosis in Alzheimer's Disease: Understanding the Role of Neutrophil Extracellular Traps (NETs) in Neuroinflammation and Disease Pathogenesis.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Oxidative stress in neurodegeneration: from a simple insult to a dynamic regulator.Redox report : communications in free radical research · 2026Review
- Insights into programmed cell death from multiple imaging modalities.Journal of translational medicine · 2026Review
- β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?International journal of molecular sciences · 2026Review
- Phosphorylated Tau Biomarkers in Alzheimer's Disease: From Early Detection to Clinical Potential-A Comprehensive Review.Molecular neurobiology · 2026Review
- Borrelia burgdorferi-Induced Neuroinflammation in Lyme Disease: A Potential Driver of Alzheimer's Disease Pathology?Molecular neurobiology · 2026Review
- Mechanistic insights into the synaptic damage-repair and regeneration processes in neurodegenerative Alzheimer's disease: phytochemicals as neuroprotective agents.Frontiers in synaptic neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Alzheimer's disease (AD) is a common neurodegenerative disease of the elderly and the sixth leading cause of death. Various risk factors are responsible for the disease, including aging, vascular disorders, head trauma, infection, genetics, and environmental conditions. Amyloid beta (Aβ) and neurofibrillary tangle (NFT) build-up lead to the generation of free radicals, which in turn cause oxidative stress and neuroinflammation that further cause synaptic and mitochondrial dysfunction. These inflammatory responses primarily stem from the overactivation of microglial and astroglial cells, producing cytokines and chemokines. However, immune cell migration has also been observed in the central nervous system (CNS) via blood-brain barrier (BBB) disruption, in which neutrophils have grabbed more attention due to their migration and formation of neutrophil extracellular traps (NETs) in AD brain parenchyma and blood vessels, causing chronic neuroinflammation and neuronal damage via NETosis. NETosis is the immune system's defense mechanism in which neutrophils form web-like structures to trap pathogens and digest them with their antimicrobial and cytotoxic peptides and release inflammatory cytokines. Neutrophils and NETs have been observed in many studies surrounding Aβ plaques in the brain parenchyma and cerebral blood vessels, causing neuronal tissue damage and AD progression. The ongoing research advocates that by targeting conventional Aβ plaques and tau build-up, managing neuroinflammation, particularly caused by NETosis, may delay the onset or reduce its progression. In the growing health care scenario, to avoid any side effects and the cost of the present discovered drugs, the focus should be on organic or natural components/compounds for which phytochemicals will be the best to target NETosis, as they have many medicinal properties like anti-oxidant, anti-inflammatory, anti-microbial, and immunomodulatory. This review focuses on understanding the molecular association between neuroinflammation in NETs and AD progression and the role of plant-derived constituents in tackling the NETosis-induced AD progression.
Indexed as
Identifiers
41460435What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.